Skip to main content
. 2014 Feb 26;9(2):e90167. doi: 10.1371/journal.pone.0090167

Table 1. Characteristic of the included studies in this meta-analysis.

First author, Publication year Countrya Study period Age Sex Cases/Cohort Case diagnosis measurement method Matching or adjustment
Cohort studies
Benson, 2008 5 1996–2001/6.2 50–65 F 390/1,249,670 Cancer registry Self-reported Age, height, strenuous exercise, socioeconomic level, smoking, alcohol intake, parity, age at first birth, OC
Johnson,2011 1 1986–2004/10.5 55–85.7 F 125/291,021 Medicare data Self-reported Age.
Michaud, 2011 2–11 1991–2004/8.4 35–70 M/F 203/380,775 Cancer registry Self-reported, Measured Age, country, sex, education.
Wiedmann,2013 4 1984–1986/23.5 ≥20 M/F 81/74,242 Cancer registry Measured Age, sex
Case-control studies
Claus,2013 1 2006–2011 29–79 F 1,127/1,092 Cancer registry Self-reported Age, sex, residence, race, education, menopause status, age at menopause, age at menarche, smoking, alcohol use, breastfeeding, OC, HRT, number of FLB, age at FTP.
Custer,2006 1 1995–1998 ≥18 F 143/286 Pathology reports Self-reported Age, race, marital status

M, male; F, female; OC, oral contraceptive; HRT, hormone replacement therapy; FLB, first live birth; FTP, full-term pregnancy.

a

Studies were conducted in: (1) USA, (2) Sweden, (3) Denmark, (4) Norway, (5) United Kingdom, (6) France, (7) Netherlands, (8) Spain, (9) Italy, (10) Germany, (11) Greece.